Sort Through Options for ESBL, CRE, and Resistant Pseudomonas

November 2020

We're getting questions about how to treat multidrug-resistant (MDR) gram-negative infections.

These infections are often caused by extended-spectrum beta-lactamase (ESBL) producers...carbapenem-resistant Enterobacterales (CRE)...or Pseudomonas with "difficult-to-treat resistance" (DTR).

Be ready to answer questions and work with your ID team.

Get unlimited access through an Enterprise license

Hospital Pharmacist's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
300+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Learn More

Already a subscriber? Log in

Not sold to individuals

Infectious Diseases Answer Questions About Using Steroids for COVID-19
Hemorrhage Optimize Safe Use of IV Tranexamic Acid
Infectious Diseases Sort Through Options for ESBL, CRE, and Resistant Pseudomonas
Nausea & Vomiting Combine Antiemetics and Peri-Op Strategies for PONV Prophylaxis
Practice Explain Limitations of COVID-19 Antibody Testing
Asthma Describe the Role of Trelegy and Triple Therapy for Asthma
Practice Evaluate if Guideline Recommendations "Fit" Your Patients
Med Administration Share Tips About Cutting, Crushing, or Giving Meds Via Tubes
Fever Improve Accuracy of Noncontact Infrared Thermometers

Sort Through Options for ESBL, CRE, and Resistant Pseudomonas

Get unlimited access through an Enterprise license

Table of Contents